n-benzyladriamycin-14-valerate and cytochrome c-t

n-benzyladriamycin-14-valerate has been researched along with cytochrome c-t in 2 studies

Compound Research Comparison

Studies (n-benzyladriamycin-14-valerate)	Trials (n-benzyladriamycin-14-valerate)	Recent Studies (post-2010) (n-benzyladriamycin-14-valerate)	Studies (cytochrome c-t)	Trials (cytochrome c-t)	Recent Studies (post-2010) (cytochrome c-t)
25	0	3	11,809	21	5,125

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Barrett, CM; Israel, M; Lothstein, L; Savranskaya, L; Sweatman, TW	1
Lothstein, L; Savranskaya, L; Sweatman, TW	1

Other Studies

2 other study(ies) available for n-benzyladriamycin-14-valerate and cytochrome c-t

Article	Year
N-benzyladriamycin-14-valerate (AD 198) activates protein kinase C-delta holoenzyme to trigger mitochondrial depolarization and cytochrome c release independently of permeability transition pore opening and Ca2+ influx. Anti-cancer drugs, 2006, Volume: 17, Issue:5 Topics: Amino Acid Chloromethyl Ketones; Animals; Apoptosis; Biological Transport; Calcium; Cell Line; Cytochromes c; Doxorubicin; Enzyme Activation; Granulocyte Precursor Cells; Membrane Potential, Mitochondrial; Mice; Mitochondrial Membrane Transport Proteins; Mitochondrial Membranes; Mitochondrial Permeability Transition Pore; Protein Kinase C-delta	2006
N-Benzyladriamycin-14-valerate (AD 198) cytotoxicty circumvents Bcr-Abl anti-apoptotic signaling in human leukemia cells and also potentiates imatinib cytotoxicity. Leukemia research, 2007, Volume: 31, Issue:8 Topics: Antibiotics, Antineoplastic; Apoptosis; Benzamides; Cytochromes c; Doxorubicin; Drug Resistance, Neoplasm; Drug Synergism; Fusion Proteins, bcr-abl; HL-60 Cells; Humans; Imatinib Mesylate; Immunoblotting; K562 Cells; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Phosphorylation; Piperazines; Protein Kinase C; Pyrimidines; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; STAT5 Transcription Factor	2007

Article

Year

N-benzyladriamycin-14-valerate (AD 198) activates protein kinase C-delta holoenzyme to trigger mitochondrial depolarization and cytochrome c release independently of permeability transition pore opening and Ca2+ influx.

Anti-cancer drugs, 2006, Volume: 17, Issue:5

Topics: Amino Acid Chloromethyl Ketones; Animals; Apoptosis; Biological Transport; Calcium; Cell Line; Cytochromes c; Doxorubicin; Enzyme Activation; Granulocyte Precursor Cells; Membrane Potential, Mitochondrial; Mice; Mitochondrial Membrane Transport Proteins; Mitochondrial Membranes; Mitochondrial Permeability Transition Pore; Protein Kinase C-delta

2006

N-Benzyladriamycin-14-valerate (AD 198) cytotoxicty circumvents Bcr-Abl anti-apoptotic signaling in human leukemia cells and also potentiates imatinib cytotoxicity.

Leukemia research, 2007, Volume: 31, Issue:8

Topics: Antibiotics, Antineoplastic; Apoptosis; Benzamides; Cytochromes c; Doxorubicin; Drug Resistance, Neoplasm; Drug Synergism; Fusion Proteins, bcr-abl; HL-60 Cells; Humans; Imatinib Mesylate; Immunoblotting; K562 Cells; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Phosphorylation; Piperazines; Protein Kinase C; Pyrimidines; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; STAT5 Transcription Factor

2007